These results are in line with epidemiological studies that mostly showed significant associations between the use of statins and lower PSA-levels, reduced incidence of clinically significant and advanced PCa, decreased recurrence rates after local treatment as well as better survival outcome [7, 9, 19–21]. The gene discussed is KLK3; the disease is posterior cortical atrophy.